6 Results for "

CLC-1

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "CLC-1" in MCE Product Catalog:

Cat. No.: HY-158183
CAS No.: 2354321-33-6
Purity:  99.60%
Synonyms: NMD670
Target:  

Chloride Channel

Research Areas:  

Neurological Disease

NMD670 is an orally active inhibitor of skeletal muscle specific chloride channel ClC-1 with an EC50 of 1.6 μM. NMD670 enhances neuromuscular transmission and improves muscle contraction and strength. NMD670 can be used in the study of muscle weakness and muscle fatigue [1] .
loading...
    loading...
Cat. No.: HY-122732
CAS No.: 5970-15-0
OADS is a Chloride channel antiporter (ClC-ec1) inhibitor (IC50: 29 μM). OADS specifically inhibits the ClC-ec1 antiporter but not the ClC-1 channel. OADS can be used for research of osteoporosis and neurodegenerative and cardiovascular diseases [1].
loading...
    loading...
Cat. No.: HY-P703106
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CLCN1; Chloride Channel Protein 1; Chloride Voltage-Gated Channel 1; Chloride Channel, Voltage-Sensitive 1; CLC-1; Chloride Channel 1, Skeletal Muscle; CLC1; Thomsen Disease, Autosomal Dominant; Chloride Channel Protein, Skeletal Muscle; Uncharacterized P
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-RS02753
Research Areas:  

Others

CLCN1 Human Pre-designed siRNA Set A contains three designed siRNAs for CLCN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-186078
Target:  

Chloride Channel

Research Areas:  

Cardiovascular Disease

SRA-36 is a CLC-K chloride channel inhibitor with selectivity over CLC-5 and CLC-1 chloride channels. SRA-36 blocks CLC-Ka currents with an IC50 of 6.6 μM and a Kd of 3.8 μM. SRA-36 blocks chloride currents mediated by targeted channels, and inhibits currents from hypertension-associated CLC-Ka A447T and CLC-Ka Y315F polymorphisms. SRA-36 can be used for the research of hypertension [1].
loading...
    loading...
Cat. No.: HY-182571
CAS No.: 15437-29-3
Target:  

Chloride Channel

Research Areas:  

Neurological Disease

AK-42 is a selective CLC-2 chloride channel inhibitor with human IC50 of 17 nM and rat IC50 of 14 nM. AK-42 binds to an extracellular vestibule above the channel pore, inhibits CLC-2 currents acutely and reversibly, including with auxiliary subunit GlialCAM coexpression. AK-42 acts as a selective tool compound for acute CLC-2 function modulation to probe CLC-2 neurophysiology. AK-42 can be used for the research of leukodystrophy and idiopathic generalized epilepsies [1].
loading...
    loading...